OMEICOS Therapeutics GmbH - IBB Beteiligungsgesellschaft Berlin

IBB Beteiligungsgesellschaft Berlin

IBB Beteiligungsgesellschaft provides venture capital to innovative Berlin-based companies and has established itself as a market leader in the field of early stage financing in Germany. The funds are used primarily for the development and market launch of innovative products or services, as well as for business concepts of creative industries. Currently two of the funds managed by the IBB Beteiligungsgesellschaft are in the investment phase, the VC Fonds Technologie Berlin II with a fund size of 60 million euros and the VC Fonds Kreativwirtschaft Berlin II with a fund size of 40 million euros. Both VC funds are financed by means of the Investitionsbank Berlin (IBB) and the European Fund for Regional Development (EFRE) administered by the State Berlin. Since 1997 the IBB Beteiligungsgesellschaft, in consortia with partners, has made 1.25 billion euros available to creative and technology-orientated companies; thereof, the portion invested by IBB Beteiligungsgesellschaft itself, as lead, co-lead or co-investor, was approximately 173 million euros.
 
Contact:
IBB Beteiligungsgesellschaft
Bundesallee 210
10719 Berlin
 
Tel: +49 (0)30 2125 3201
 

ico linkwww.ibb-bet.de